 It's very surprising what some of those documents say in the ICRP 111. We'll be talking about that. So you've got ICRP, which issues guidance. You've got FDA that has their own guidance. We need to get clarity on what it all means. And by bringing this before Congress, we're hoping that lawmakers will take action and that their constituents will continue to